NO20002371L - 2-Arylbenzo[b]tiofener til behandling av østrogen- deprivasjonssyndrom - Google Patents

2-Arylbenzo[b]tiofener til behandling av østrogen- deprivasjonssyndrom

Info

Publication number
NO20002371L
NO20002371L NO20002371A NO20002371A NO20002371L NO 20002371 L NO20002371 L NO 20002371L NO 20002371 A NO20002371 A NO 20002371A NO 20002371 A NO20002371 A NO 20002371A NO 20002371 L NO20002371 L NO 20002371L
Authority
NO
Norway
Prior art keywords
arylbenzo
thiophenes
treatment
estrogen deprivation
deprivation syndrome
Prior art date
Application number
NO20002371A
Other languages
English (en)
Other versions
NO20002371D0 (no
Inventor
George Joseph Cullinan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20002371D0 publication Critical patent/NO20002371D0/no
Publication of NO20002371L publication Critical patent/NO20002371L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Oppfinnelsen tilveiebringer fremgangsmåter som er nyttige ved hemming av forskjellige medisinske tilstander forbundet med østrogen-deprivasjonssyndrom inkludert osteoporose og hyperlipidemi ved å benytte forbindelser med formel (I).
NO20002371A 1997-11-14 2000-05-05 2-Arylbenzo[b]tiofener til behandling av østrogen- deprivasjonssyndrom NO20002371L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6585497P 1997-11-14 1997-11-14
PCT/US1998/023719 WO1999025707A1 (en) 1997-11-14 1998-11-09 2-ARYLBENZO[b]THIOPHENES USEFUL FOR THE TREATMENT OF ESTROGEN DEPRIVATION SYNDROME

Publications (2)

Publication Number Publication Date
NO20002371D0 NO20002371D0 (no) 2000-05-05
NO20002371L true NO20002371L (no) 2000-07-05

Family

ID=22065580

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002371A NO20002371L (no) 1997-11-14 2000-05-05 2-Arylbenzo[b]tiofener til behandling av østrogen- deprivasjonssyndrom

Country Status (20)

Country Link
US (2) US6096781A (no)
EP (1) EP0920862A1 (no)
JP (1) JP2001523676A (no)
KR (1) KR20010031903A (no)
CN (1) CN1109683C (no)
AU (1) AU748395B2 (no)
BR (1) BR9813996A (no)
CA (1) CA2309859A1 (no)
EA (1) EA003471B1 (no)
HR (1) HRP20000288A2 (no)
HU (1) HUP0004731A3 (no)
ID (1) ID26865A (no)
IL (1) IL135511A0 (no)
NO (1) NO20002371L (no)
NZ (1) NZ503988A (no)
PL (1) PL340431A1 (no)
TR (1) TR200001288T2 (no)
TW (1) TW467909B (no)
WO (1) WO1999025707A1 (no)
ZA (1) ZA9810214B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
USRE38968E1 (en) 1992-07-28 2006-02-07 Eli Lilly And Company Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
USRE39049E1 (en) 1992-07-28 2006-03-28 Eli Lilly And Company Methods for inhibiting bone loss
US5478847A (en) 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
US6096781A (en) 1997-11-14 2000-08-01 Eli Lilly And Company 2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome
US6087378A (en) * 1998-10-13 2000-07-11 Eli Lilly And Company Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome
DE19913349A1 (de) * 1999-03-24 2000-09-28 Clariant Gmbh Benzothiophene und ihre Verwendung in flüssigkristallinen Mischungen
EP1585384B1 (en) * 2002-02-20 2012-07-11 J.R. Simplot Company Precise breeding
AU2002953533A0 (en) 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
US20060106010A1 (en) * 2003-05-27 2006-05-18 Black Larry J Methods for inhibiting bone loss
ITTO20040125A1 (it) * 2004-03-01 2004-06-01 Rotta Research Lab Nuove amidine eterocicliche inibitrici la produzione di ossido d'azoto (no) ad attivita' antinfiammatoria ed analgesica
JP2007523213A (ja) * 2004-12-23 2007-08-16 テバ ファーマシューティカル インダストリーズ リミティド 医薬的に許容できるデュロキセチンの塩及びその中間体の調製方法
KR101123178B1 (ko) * 2009-04-09 2012-06-13 (주)에스메디 2-아릴벤조싸이오펜 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물
EP2912033A4 (en) 2012-10-24 2016-09-14 Univ Illinois COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-MEDIATED ILLNESSES
US9475791B2 (en) 2012-10-24 2016-10-25 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating estrogen-related medical disorders
CN107325067B (zh) * 2017-05-03 2020-05-12 广州中医药大学 磷酸二酯酶4抑制剂桑辛素m衍生物及其用途

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4588484A (en) * 1985-02-28 1986-05-13 Eli Lilly And Company Electrochemical reduction of 3-chlorobenzo[b]thiophenes
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
TW383306B (en) * 1992-12-22 2000-03-01 Lilly Co Eli New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
US5391557A (en) * 1993-10-15 1995-02-21 Eli Lilly And Company Methods for the treatment of peri-menopausal syndrome
US5552415A (en) * 1993-12-21 1996-09-03 Eli Lilly And Company Method of inhibiting Alzheimer's Disease
US5389670A (en) * 1993-12-21 1995-02-14 Eli Lilly Company Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
US5534526A (en) * 1993-12-21 1996-07-09 Eli Lilly And Company Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome
US5462950A (en) * 1993-12-21 1995-10-31 Eli Lilly And Company Methods of treating menstrual symptoms and compositions therefore
US5591753A (en) * 1994-01-28 1997-01-07 Eli Lilly And Company Combination treatment for osteoporosis
US5811120A (en) * 1994-03-02 1998-09-22 Eli Lilly And Company Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
US5972383A (en) * 1994-03-02 1999-10-26 Eli Lilly And Company Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
US5478847A (en) * 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
US5510357A (en) * 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
ATE207913T1 (de) * 1995-02-28 2001-11-15 Lilly Co Eli Benzothiophen-verbindungen, zwischenprodukte, zusammensetzungen und verfahren
US5514703A (en) * 1995-03-13 1996-05-07 Eli Lilly And Company Benzothiophene compounds useful for inhibiting lipoxygenase
US5532382A (en) * 1995-03-13 1996-07-02 Eli Lilly And Company Benzothiophenes substituted at the 3-carbonyl
US5514704A (en) * 1995-03-13 1996-05-07 Eli Lilly And Company Benzothiophenes to inhibit leukotrienes
US5550134A (en) * 1995-05-10 1996-08-27 Eli Lilly And Company Methods for inhibiting bone loss
US6444688B1 (en) * 1995-06-07 2002-09-03 Eli Lilly And Company Compounds and compositions with nitrogen-containing non-basic side chains
DE69611452T2 (de) * 1995-06-26 2001-06-13 Lilly Co Eli Benzothiophenderivate
US5731342A (en) * 1996-02-22 1998-03-24 Eli Lilly And Company Benzothiophenes, formulations containing same, and methods
ZA982877B (en) * 1997-04-09 1999-10-04 Lilly Co Eli Treatment of central nervous system disorders with selective estrogen receptor modulators.
US6096781A (en) * 1997-11-14 2000-08-01 Eli Lilly And Company 2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome
ID24978A (id) * 1997-11-14 2000-08-31 Lilly Co Eli 2-ARYL-3-AROYLBENZO (b) THIOPHENES BERGUNA UNTUK PENGOBATAN SINDROM DEPRIVASI ESTROGEN

Also Published As

Publication number Publication date
HUP0004731A2 (hu) 2001-08-28
EA200000519A1 (ru) 2000-10-30
US6395769B1 (en) 2002-05-28
HUP0004731A3 (en) 2003-01-28
TW467909B (en) 2001-12-11
PL340431A1 (en) 2001-02-12
NZ503988A (en) 2001-09-28
TR200001288T2 (tr) 2000-09-21
JP2001523676A (ja) 2001-11-27
NO20002371D0 (no) 2000-05-05
HRP20000288A2 (en) 2000-08-31
ID26865A (id) 2001-02-15
CN1109683C (zh) 2003-05-28
EA003471B1 (ru) 2003-06-26
US6096781A (en) 2000-08-01
BR9813996A (pt) 2000-09-26
WO1999025707A1 (en) 1999-05-27
CA2309859A1 (en) 1999-05-27
AU748395B2 (en) 2002-06-06
ZA9810214B (en) 2000-05-09
KR20010031903A (ko) 2001-04-16
AU1386199A (en) 1999-06-07
IL135511A0 (en) 2001-05-20
CN1278811A (zh) 2001-01-03
EP0920862A1 (en) 1999-06-09

Similar Documents

Publication Publication Date Title
NO20002371L (no) 2-Arylbenzo[b]tiofener til behandling av østrogen- deprivasjonssyndrom
LU91271I2 (fr) Natalizumab et ses dérivés pharmaceutiquement acceptables (TYSABRI)
AU5242000A (en) Nematicidal trifluorobutenes
NO20065784L (no) Steroidforbindelser og anvendelse av slike
NO20002172L (no) FremgangsmÕte for behandling av hyperkolesterolemi med usubstituert polydiallylamin
NO991793D0 (no) FremgangsmÕte for anvendelse av cyklooksygenase-2 inhibitorer ved behandlingen og forebyggingen av neoplasia
JO2409B1 (en) Second-phenyl carboxy amides are useful as lipid-lowering agents
TNSN05306A1 (en) Substituted pyrrole derivatives.
WO1999063976A3 (en) Liver-selective glucocorticoid antagonist for treating diabetes
AU2251901A (en) Methods and compounds for inhibiting MRP1
WO2004043456A8 (en) Cholesterol absorption inhibitors for the treatment of demyelination
DK0888323T3 (da) Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler
JO2390B1 (en) Diphenylcarboxamides act as lipid-lowering agents
ZA9810215B (en) 2-Aryl-3-Aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome.
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
BG105953A (en) Method for treating copd
ZA979647B (en) Heterocyclic compounds, compositions and uses.
NO20002408L (no) 5-HT1F antagonister
AU6479000A (en) Novel use of prodigiosin for treating diabetes mellitus
AU7718796A (en) 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
ZA979650B (en) Heterocyclic compounds, compositions and uses.
ZA979645B (en) Heterocyclic compounds, compositions and uses.
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
HUP0203741A2 (hu) Eljárás oszteoporózis kezelésére
NZ523676A (en) Use of cetyl myristate and cetyl palmitate to treat irritable bowel syndrome or irritable bowel disease

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application